Travere Therapeutics, Inc. (TVTX)

NASDAQ: TVTX · Real-Time Price · USD

51.56

-0.48 (-0.92%)

Nov 12, 2026, 4:00 PM EST - Market closed

Travere Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	4,949	3,419	1,516	676	1,350	1,900
Market Cap Growth	53.19%	125.49%	124.43%	-49.94%	-28.99%	36.59%
Enterprise Value	5,094	3,494	1,641	446	1,251	1,609
Last Close Price	51.56	38.21	17.42	8.99	21.03	31.04

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	10.95	38.08	42.85	42.85	42.85	42.85
PS Ratio	7.60	6.97	6.50	4.65	12.33	14.42
PB Ratio	218.43	29.77	25.66	3.36	31.49	6.29
P/TBV Ratio	-	3561.19	-	7.01	-	12.37
P/FCF Ratio	27.97	90.48	-	-	-	-
P/OCF Ratio	28.03	90.48	-	-	-	-
PEG Ratio	-	2.20	2.20	2.20	2.20	2.20

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	7.82	7.12	7.04	3.07	11.43	12.21
EV/FCF Ratio	28.78	92.47	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	27.28	2.86	6.80	2.02	9.51	0.87
Debt / EBITDA Ratio	16.74	141.76	-	-	-	-
Debt / FCF Ratio	3.48	8.70	-	-	-	-
Net Debt / Equity Ratio	6.39	0.05	0.52	-0.81	-1.00	-0.96
Net Debt / EBITDA Ratio	4.45	-2.85	-0.14	0.48	0.14	1.56
Net Debt / FCF Ratio	0.82	0.16	-0.13	0.58	0.23	14.62
Asset Turnover	0.94	0.82	0.34	0.20	0.15	0.19
Inventory Turnover	31.56	35.83	28.86	36.81	39.16	27.48
Quick Ratio	2.76	2.53	1.99	3.33	3.30	4.59
Current Ratio	3.00	2.74	2.08	3.47	3.42	4.70
Return on Equity (ROE)	-321.22%	-57.80%	-246.75%	-308.90%	-192.18%	-84.66%
Return on Assets (ROA)	-1.84%	-6.55%	-23.15%	-32.22%	-27.58%	-18.01%
Return on Capital Employed (ROCE)	-3.20%	-14.10%	-65.10%	-61.70%	-60.30%	-30.60%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-2.55%	-0.75%	-21.21%	-16.49%	-20.64%	-9.48%
FCF Yield	3.58%	1.10%	-15.66%	-41.45%	-13.80%	-1.05%
Buyback Yield / Dilution	-5.90%	-13.08%	-6.22%	-16.48%	-6.56%	-25.86%

SEC Filings: 10-K · 10-Q